Searched for
CANCER CARE TRAINING
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIt is probably time to be bullish as an investor. But remember two things. One: Valuations are still not cheap. Two: Because it is over and...- Scorpio ♏ July 2026 Horoscope, Monthly Predictions: Something Big Could Be Happening Behind the Scenes♏ Scorpio Monthly Horoscope (1st July 2026 to 31st July 2026): The Scorpio Monthly Horoscope brings a month of deep reflection. The Sun rem...
- Libra ♎ July 2026 Horoscope, Monthly Predictions: Venus in Leo Unlocks Powerful Opportunities and New Alliances♎ Libra Monthly Horoscope (1st July 2026 to 31st July 2026): The Libra Monthly Horoscope brings a strong focus on career growth and long-te...
- Virgo ♍ July 2026 Horoscope, Monthly Predictions: Unexpected Delays Could Open the Door to Bigger Opportunities♍ Virgo Monthly Horoscope (1st July 2026 to 31st July 2026): The Virgo Monthly Horoscope indicates a month focused on career and long-term ...
- Pisces ♓ Weekly Horoscope (22nd June - 28th June 2026): Emotional Clarity, Career Growth & New Opportunities AheadPisces Weekly Horoscope (22nd June 2026 to 28th June 2026): Your pisces weekly horoscope indicates a meaningful and progressive week. The M...
- Scorpio Weekly Horoscope (15th June - 21st June 2026): Partnerships Take Center Stage as Major Changes UnfoldScorpio Weekly Horoscope (15th June 2026 to 21st June 2026): This weekly horoscope indicates a significant week of change. The Moon will tr...
- Libra Weekly Horoscope (15th June - 21st June 2026): Major Career Development May Be Closer Than You ThinkLibra Weekly Horoscope (15th June 2026 to 21st June 2026): This weekly horoscope indicates an encouraging and progressive week. The Moon wi...
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%At a time when there are so many headwinds for the markets, it is tough to imagine that things can get better. But sentiment is a fickle th...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Volatility as opportunity, depends on framework of mind: 5 mid-caps from different sectors with upside potential of up to 31%The Indian stock market is no longer correcting only because of sentiment. It is now adjusting to the possibility of weaker numbers in the ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Health services, medical education expansion to be driven by modern tech: Yogi AdityanathUttar Pradesh Chief Minister Yogi Adityanath reviewed health and medical education. He stressed improving treatment quality and expanding s...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Cancer burden rising, all hands on the deckIndia faces a critical shortage of cancer specialists. A new rule for the PMJAY scheme now bars experienced oncologists without specific de...
- New PMJAY rule bars hundreds of experienced cancer specialists from treating patients under Ayushman Bharat schemeAround 15 lakh cancer cases are detected in India every year, yet several states are excluding hundreds of experienced, fellowship-trained ...
Load More
